/business/Curie-Ablaze-launch-radiopharma-drugs/99/i44 20211204 Concentrates 99 44 /magazine/99/09944.html Curie, Ablaze launch for radiopharma drugs Radiopharmaceuticals, oncology, drug discovery con bus Michael McCoy business pharmaceuticals oncology Curie, Ablaze launch for radiopharma drugs Chemical & Engineering News Curie, Ablaze launch for radiopharma drugs Curie, Ablaze launch for radiopharma drugs
by Michael McCoy | December 04, 2021
Sanofi says it will work with Owkin in oncology areas including lung cancer, breast cancer, and multiple myeloma. Athos Therapeutics, a specialist in autoimmune disorders, has raised $15 million in series A financing. The money will support preclinical and clinical programs and development of its artificial intelligence–driven drug discovery platform.
November 24, 2021
/pharmaceuticals/drug-discovery/10-Start-Ups-to-Watch-2021-Kojin-Therapeutics/99/i42 20211121 Developing small-molecule drugs that exploit a new type of cell death, ferroptosis 99 42 /magazine/99/09942.html Kojin Therapeutics Drug discovery, Kojin, ferroptosis, biotech, oncology bus Lisa M. Jarvis pharmaceuticals drug-discovery business start-ups Stuart Schreiber (left) and Vasanthi Viswanathan, two of Kojin Therapeutics' cofounders In a type of cell death known as ferroptosis, cancer cells oxidize polyunsaturated lipids to form lipid peroxides, which in turn react with iron to form lipid radicals that cause the cells to die.
by Lisa M. Jarvis | November 21, 2021
Sean Marchese, a registered nurse and oncology medical writer with the advocacy organization the Mesothelioma Center, still thinks soil caps are a relatively safe method of asbestos remediation, but says the EPA should ensure that people are made aware of the potential risks this study identifies. “It comes down to people being able to make their own decisions based on the information that’s out there,” Marchese says.
by Gina Vitale | November 19, 2021
Tom Plasterer, AstraZeneca’s senior director for strategy and collaborations in oncology translational medicine, agrees that standardization continues to vex the field but says that the pharmaceutical industry has made headway with the help of data standard repositories such as the National Center for Biomedical Ontologies’ BioPortal.
by Rick Mullin | November 07, 2021
This improved safety and efficacy profile “provides us with an opportunity to go into previously inaccessible combinations,” says Genentech’s Anwesha Dey, director and principal scientist of discovery oncology, who now leads the research side of this program. Genentech also found that this inavolisib-induced degradation relies on the activity of HER2 or related receptors at the cell membrane.
by Asher Mullard, special to C&EN | October 31, 2021
Prokarium, a British specialist in microbial oncology therapies, has picked Wacker Biotech to manufacture its Salmonella-based immunotherapy for bladder cancer. Wacker will employ its live microbial products manufacturing plant in Amsterdam. Angus Chemical plans to expand US production of tromethamine buffers, which are building blocks and emulsifying agents used in drugs, cosmetics, and other products.
October 23, 2021
/pharmaceuticals/oncology/AUM-Biosciences-raises-27-million/99/i38 20211015 Concentrates 99 38 /magazine/99/09938.html AUM Biosciences raises $27 million for cancer drugs pharmaceuticals, oncology con bus Ryan Cross pharmaceuticals oncology business start-ups AUM raises $27 million for cancer drugs Chemical & Engineering News AUM Biosciences raises $27 million for cancer drugs AUM Biosciences raises $27 million for cancer drugs
by Ryan Cross | October 15, 2021
LeBlanc, director of the comparative oncology program at the National Cancer Institute (NCI). She is not involved in VACCS. “If you have a dog, it probably slept in your bed with you last night. It eats scraps from your table and goes on walks with you through your neighborhood,” she says. “So the immune repertoire [dogs] have is likely more akin to what we have.”
by Alla Katsnelson, special to C&EN | October 10, 2021
Torres, SARS-CoV2, Staphylococcus aureus, super-resolution microcopy, neuro-oncology con scitech Alla Katsnelson, special to C&EN people awards Victor J. Torres Trevor Bedford Ibrahim Cissé Michelle Monje John D. and Catherine T. MacArthur Foundation John D. and Catherine T. MacArthur Foundation John D. and Catherine T.
by Alla Katsnelson, special to C&EN | September 29, 2021